Stories about Medizin, Gesundheit
- 5more
Ottobock SE & Co. KGaA categorically rejects misleading allegations in short-seller report
moreAnnual General Meeting approves dividend of EUR 0.97 per share
moreOttobock continues strategic expansion of its Patient Care network with acquisition
more- 6
Ottobock will be presenting innovative prosthetics and orthotics solutions at OTWorld 2026.
more Europäischer Rechnungshof - European Court of Auditors
Koronakriisin jälkeinen miljardien eurojen arvoinen EU:n elpymisrahasto ei ole riittävän avoin
more
Interview with Intellicant-Experte Fabien Patrick
more- 4
GEA presents a smart decanter at IFAT 2026
more Technische Universität München
Stem Cell Research: Reading Genetic Activity from Living Cells without Destroying Them
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Tool for Better Control of Stem Cell Development Reading Genetic Activity from Living Cells without Destroying Them - Multi-day gene activity profiles from the same cells - Long-term analysis of cell communication in mixed cultures - Potential applications in organoids and tumor microenvironments Until now, studying the ...
morePress Release: STADA strengthens CHC local hero brand portfolio by acquiring Locobase derma line in Nordics
STADA strengthens CHC local hero brand portfolio by acquiring Locobase derma line in Nordics - STADA strengthens Consumer Healthcare presence in Nordic countries by acquiring rights to Locobase® dermatology brand - Locobase® range of 17 products ...
One documentmoreLTS Lohmann Therapie-Systeme AG
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...
moreVITUS Privatklinik Prof. Dr. Stehling GmbH
First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response
OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...
more
LAUDA DR. R. WOBSER GMBH & CO. KG
2LAUDA Presents the Dr.-Rudolf-Wobser-Medal to Indian Partner Sandeep Sawant
moreLAUDA DR. R. WOBSER GMBH & CO. KG
4Temperature Control Specialist Honors Global Sales Achievements
moreWorld Intellectual Property Day: Ottobock builds on its leadership in innovation
more- 5
GEA introduces new brine injector for small- to mid-capacity lines
more Explore and Experience: FIBO 2026 Brings Healthy Living to Life
Cologne (ots) - Fitness is more than just training. From April 16 to 19, FIBO will transform the Cologne Exhibition Centre into an immersive world of fitness, health, and lifestyle. Visitors are invited to discover new forms of exercise, deepen their knowledge, and take-home fresh inspiration for a more active routine. Over four days, the world’s leading trade show for fitness, wellness, and health offers a diverse ...
more- 9
Sysmex officially opens the new campus in Hamburg
2 Documentsmore
Smart exoskeletons and digital ergonomics
moreFIBO 2026: AI Drives the Longevity & Health Boom
Cologne (ots) - FIBO 2026, the world’s leading trade show for fitness, wellness, and health, marks a strategic shift in the industry toward data-driven health and longevity models. Where traditional strength training once dominated, digital applications, connected systems, and AI-powered analytics are now shaping market development. FIBO is positioning itself as an international platform and catalyst for a new ...
morePress Release: Enzymatica and STADA sign partnership agreement for Germany and Austria
Press Release Enzymatica and STADA sign partnership agreement for Germany and Austria - New partnership agreement covers thelaunch and distribution of Enzymatica’s ColdZyme® oral-spray technology in Germany and Austria - Alliance combines Enzymatica’s clinically documented medical device with ...
One documentmoreFUTRUE Neurosciences Reaches Major Milestone
morecanSERV: Impact and Future Perspectives Event
moreLAUDA DR. R. WOBSER GMBH & CO. KG
LAUDA Honors Elmar Mohr for 40 Years of Service
more
- 5
PR: DHL expands its North America logistics infrastructure amid growing global demand for data center logistics services / PM: DHL expands its North America logistics infrastructure amid growing global demand for data center logistics services
2 Documentsmore - 3
New Scattered Light Method enables faster Analysis of Bacteria and Antibiotic Resistance
more - 6
World Water Day 22.03.2026: Hamburg-based Aid by Trade Foundation Improves Drinking Water Supply and Equal Opportunities for Girls in Africa
One documentmore - 2
IFAT, Munich: Invitation to the Press Conference “Smart Automation for Lower Costs”
more - 2
Press Release: STADA’s Strong Growth Journey Continues in 2025
One documentmore 100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project
EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an important milestone toward its goal, having screened 100,000 of the more than 200,000 children and adolescents ...
more